MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    Serum fractalkine levels in Parkinson’s disease: Evidence for neuroinflammation

    G. Nagesh Babu, M. Gupta, V. Paliwal (Lucknow, India)

    Objective: Parkinson's disease (PD) is a debilitating neurodegenerative disorder characterized by loss of dopamine neurons in the substantia nigra. We measured neuroinflammatory marker fractalkine in…
  • 2018 International Congress

    Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

    N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)

    Objective: To add to the current body of knowledge of the association of HIV infection and dopamine responsive parkinsonism. Background: South Africa has one of…
  • 2018 International Congress

    Quantitative Midbrain Measurement in Diagnosing Variants of Progressive Supranuclear Palsy

    H. Wang, YW. Zhang, J. Yuan, D. Xu, H. You, ML. Li, F. Feng (Beijing, China)

    Objective: To evaluate the effectiveness of quantitative midbrain measurements in differentiating vPSP from multiple system atrophy (MSA) and Parkinson’s disease (PD). Background: Newly published criteria…
  • 2018 International Congress

    ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

    N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)

    Objective: This double-blind, placebo-controlled phase 2 study (M15-562 ARISE study, NCT02985879) assesses the safety and efficacy of ABBV-8E12 treatment in patients with progressive supranuclear palsy…
  • 2018 International Congress

    Striatal FP-CIT SPECT findings for progressive supranuclear palsy subtypes

    M. Yogo, M. Morita, M. Suzuki (Tokyo, Japan)

    Objective: In our previous study FP-CIT SPECT (FP-CIT) in progressive supranuclear palsy-Parkinsonism (PSP-P) revealed higher anterior striatal accumulation, and PSP- Richardson’s syndrome (PSP-RS) revealed lower…
  • 2018 International Congress

    A longitudinal study of brain quantitative MRI analysis before and after diagnosis of progressive supranuclear palsy

    K. Seo, T. Yamamoto, H. Kawasaki, A. Miyake, T. Hukuoka, Y. Nakazato, T. Takahasi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)

    Objective: We analyzed longitudinal change in MRI imaging in PSP from the period before clinical diagnosis. Six patients with clinically diagnosed PSP including 1 case…
  • 2018 International Congress

    Cognitive impairment in multiple system atrophy: A Nepalese tertiary center study

    R. Ojha, K. Oli (Kathmandu, Nepal)

    Objective: This study was done to describe the clinical profile of MSA and evaluate the cognitive function using mini-mental state examination(MMSE). Background: Multiple system atrophy…
  • 2018 International Congress

    Probable MSA presenting initially with urinary retention

    S. Simeoni, R. Sakakibara, J. Panicker (London, United Kingdom)

    Objective: We describe 6 cases of probable MSA presenting with urinary retention/incomplete bladder emptying. Background: MSA is a progressive neurodegenerative adult-onset disease whose clinical features…
  • 2018 International Congress

    Toxin-induced Parkinsonism: A report of two patients

    Z. Aldaajani (Dhahran, Saudi Arabia)

    Objective: To highlight the presentation of parkinsonism caused by acute and chronic exposure to carbon monoxide(CO). Background: Toxin-induced parkinsonism is not uncommon. One of the…
  • 2018 International Congress

    MRI volumetrics in parkinsonian syndromes

    K. Ma, A. Chan, L. Shi, J. Abrigo, T. Cheung, C. Lau, V. Mok (Hong Kong, Hong Kong)

    Objective: We aimed to explore the ability of MRI volumetrics by using an automated segmentation software called Accubrain in differentiating (1) between different parkinsonian syndromes…
  • « Previous Page
  • 1
  • …
  • 1285
  • 1286
  • 1287
  • 1288
  • 1289
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley